What is Infab?
Established in 1981, Infab has evolved into a premier manufacturer of specialized radiation protection equipment. The company's comprehensive portfolio includes high-performance lead aprons, thyroid collars, protective eyewear, and mobile barriers designed to mitigate exposure risks for healthcare professionals and patients. By integrating advanced materials science, such as their proprietary UnderShield cooling fabric, Infab differentiates itself through a commitment to both ergonomic comfort and rigorous safety standards. Their market position is reinforced by a long-standing reputation for reliability and a robust distribution network that serves clinical environments worldwide.
How much funding has Infab raised?
Infab has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Infab
PPP
Public-Private Partnership
What's next for Infab?
The recent influx of capital is expected to catalyze Infab's next phase of growth, focusing on product innovation and manufacturing efficiency. As the healthcare sector continues to prioritize advanced safety protocols, Infab is likely to leverage this financing to scale its production capacity and explore new material technologies that enhance the protective efficacy of its gear. Strategic initiatives will likely center on maintaining its competitive edge in the radiation protection market while optimizing supply chain logistics to meet the increasing demand for high-quality medical safety solutions. This enterprise-level backing provides the necessary liquidity to pursue long-term research and development goals, ensuring the company remains at the forefront of medical safety innovation.
See full Infab company page
